Generations Offers Ultra-Low-Dose Radiotherapy for Osteoarthritis Treatment
In 2025, Generations Radiotherapy became one of the first providers in Alabama to offer ultra-low-dose radiation therapy (ULDRT) for the treatment of osteoarthritis in patients who have not had sufficient relief from routine medications or other management.  This therapy has been tested extensively in Germany and is just now beginning to see increased use in the United States, as it has been shown to be low risk and very effective.  For answers to common questions about ULDRT, see the Q&A hand-out we've created.  If you believe you might benefit from ULDRT for osteoarthritis, ask your doctor about a referral to Generations Radiotherapy, or click here to submit an inquiry.

Diagnosed with cancer?  
What's the best next step?

The most important aspect of choosing an oncology provider is finding one that cares about you, not as a diagnosis, but as a whole person.  At GenXRT, we realize that you are still the person you've always been.  Cancer does not define you, and while it may be a part of your story, it's not the most important part.  We realize that guiding you through the treatment process means creating a partnership with you.  That partnership means that we'll offer you treatment options tailored to your unique situation, and that we'll do our best to understand the impact this process has on you.  Moreover, we understand that providing high quality care isn't just our job, it's our God-given mission.  Our goal is to see you healed physically, emotionally, and spiritually.  It's our prayer
that God uses us to accomplish that goal, and that
we honor Him in the process.

SDG
​

The latest from GenXRT . . .

Dr. Christopher Jahraus named a Fellow of the American Society for Radiation Oncology (ASTRO) for contributions to cancer care
Award recognizes exceptional service to the field radiation oncology
Picture

ARLINGTON, Va., July 9, 2025— Dr. Christopher Jahraus, a physician in radiation oncology at Baptist Health Shelby Hospital and owner of Generations Radiotherapy & Oncology PC in Alabaster, was selected as a Fellow of the American Society for Radiation Oncology (FASTRO), the world’s largest professional organization in radiation oncology. Dr. Jahraus will be recognized at ASTRO’s 67th Annual Meeting in San Francisco on Tuesday, September 30.
“Dr. Jahraus joins an elite group of just 43 physicians, physicists and cancer biologists who are recognized this year for their far-reaching contributions to the field of radiation oncology and their progress in advancing research, education and patient care,” said Howard M. Sandler, MD, FASTRO, Chair of the ASTRO Board of Directors. “ASTRO proudly recognizes these achievements and congratulates Dr. Jahraus for being named an ASTRO Fellow.”
First awarded in 2006, the FASTRO designation honors ASTRO members who have made significant contributions to the Society and the field through research, education, patient care and dedicated service. Only 541 of ASTRO’s 10,000 members worldwide have received this distinction. A full list of ASTRO Fellows, along with information about the nomination and selection process, is available on the ASTRO website.
Dr. Jahraus has been actively engaged with ASTRO and its colleague organizations for many years, with roles in governmental relations and advocacy for radiation oncology pateints nationwide.  Additionally, he serves as a radiation oncology advisor to the American Medical Association’s Relative Value Update Committee, working to ensure patients’ access to care.  Beyond his advocacy work, Dr. Jahraus serves as the deputy-editor-in-chief of Contemporary Updates: Radiation Oncology Innovations & Evidence.  He is part of the clinical preceptor faculty for the Alabama College of Osteopathic Medicine in Dothan, Alabama, and lives in Chelsea with his family.